Published in Can J Cardiol on June 15, 2010
Low Cost Magnetic Resonance Imaging-Compatible Stepper Exercise Device for Use in Cardiac Stress Tests. J Med Device (2014) 0.78
Illustrated Imaging Essay on Congenital Heart Diseases: Multimodality Approach Part III: Cyanotic Heart Diseases and Complex Congenital Anomalies. J Clin Diagn Res (2016) 0.75
Aortic Function's Adaptation in Response to Exercise-Induced Stress Assessing by 1.5T MRI: A Pilot Study in Healthy Volunteers. PLoS One (2016) 0.75
Cardiac magnetic resonance in clinical cardiology. World J Cardiol (2015) 0.75
Quantification of aortic stenosis diagnostic parameters: comparison of fast 3 direction and 1 direction phase contrast CMR and transthoracic echocardiography. J Cardiovasc Magn Reson (2017) 0.75
Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging (2016) 0.75
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation (1999) 11.04
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
An improved MR imaging technique for the visualization of myocardial infarction. Radiology (2001) 7.45
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet (2002) 6.11
Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation (2005) 5.85
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol (2002) 5.74
Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol (2005) 5.63
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol (2005) 5.50
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation (2007) 5.09
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation (2006) 4.98
Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med (2001) 4.73
Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation (1998) 4.54
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 4.51
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation (2004) 4.23
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol (2002) 4.11
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation (2004) 3.76
Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson (2005) 3.47
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44
Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation (2001) 3.38
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation (2006) 3.20
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J (2004) 3.19
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2002) 3.14
The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 3.09
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2000) 2.85
The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med (1993) 2.84
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation (2005) 2.80
Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol (2003) 2.78
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood (2005) 2.75
Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation (2001) 2.73
Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J (2004) 2.68
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation (2007) 2.48
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation (2002) 2.43
Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation (1999) 2.42
Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation (2002) 2.40
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 2.31
Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol (2004) 2.21
Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation (2004) 2.20
Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation (2006) 2.18
Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest (2002) 2.15
Quantitative assessment of regional myocardial function with MR-tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with Harmonic Phase (HARP) MRI. J Cardiovasc Magn Reson (2005) 2.11
Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol (2006) 2.08
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J (2003) 2.08
Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation (2004) 2.04
Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation (2001) 2.03
Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol (2005) 2.02
MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology (2001) 2.00
Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Eur Radiol (2005) 1.99
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation (2003) 1.99
Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol (2006) 1.97
Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation (2002) 1.97
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation (2007) 1.91
Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology (2008) 1.87
Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent. J Am Coll Cardiol (2003) 1.81
Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J (2006) 1.79
Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol (2003) 1.78
Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J (2004) 1.77
Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol (2007) 1.76
Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J (2004) 1.76
Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation (2003) 1.73
Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J (2004) 1.68
Post-ischaemic myocardial dysfunction (stunning) results from myofibrillar oedema. Heart (2007) 1.67
Contrast-enhanced cardiac magnetic resonance in a patient with familial isolated ventricular non-compaction. J Cardiovasc Magn Reson (2004) 1.65
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol (1998) 1.64
Noninvasive imaging in myocarditis. J Am Coll Cardiol (2006) 1.62
Anatomical and functional evaluation of pulmonary veins in children by magnetic resonance imaging. J Am Coll Cardiol (2007) 1.62
Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation (1995) 1.57
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation (1993) 1.55
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart (2001) 1.51
Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J (2002) 1.46
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol (1998) 1.45
Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation (2005) 1.43
Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology (1992) 1.41
Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J (2006) 1.41
Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation (2002) 1.40
In vitro validation of phase-contrast flow measurements at 3 T in comparison to 1.5 T: precision, accuracy, and signal-to-noise ratios. J Magn Reson Imaging (2005) 1.37
How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping. J Cardiovasc Magn Reson (2005) 1.30
Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol (2007) 1.30
Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol (2003) 1.29
Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue doppler imaging and velocity-encoded magnetic resonance imaging. J Am Coll Cardiol (2006) 1.28
Cine MRI using steady state free precession in the radial long axis orientation is a fast accurate method for obtaining volumetric data of the left ventricle. J Magn Reson Imaging (2001) 1.24
Myocardial tissue phase mapping with cine phase-contrast mr imaging: regional wall motion analysis in healthy volunteers. Radiology (2006) 1.18
Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J (2003) 1.15
Clinical applications of cardiovascular magnetic resonance imaging. CMAJ (2006) 1.14
Head-to-head comparison of three-dimensional navigator-gated magnetic resonance imaging and 16-slice computed tomography to detect coronary artery stenosis in patients. J Am Coll Cardiol (2005) 1.14
Assessment of regional myocardial oxygenation changes in the presence of coronary artery stenosis with balanced SSFP imaging at 3.0 T: theory and experimental evaluation in canines. J Magn Reson Imaging (2008) 1.12
The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson (2006) 1.12
The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation (2000) 1.10
Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg (2005) 1.09
Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation (2003) 1.08
Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace (2007) 1.07
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol (2005) 5.50
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA (2011) 4.14
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation (2004) 3.76
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17
Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2009) 2.90
Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med (2007) 2.72
Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 2.34
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. JACC Cardiovasc Imaging (2011) 2.22
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging (2007) 2.01
Unusual myocardial late gadolinium enhancement in isolated noncompaction cardiomyopathy. Echocardiography (2014) 1.97
T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson (2003) 1.88
T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson (2011) 1.79
Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn Reson Med (2013) 1.69
Noninvasive imaging in myocarditis. J Am Coll Cardiol (2006) 1.62
Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol (2007) 1.41
The evolving approach to paediatric myocarditis: a review of the current literature. Cardiol Young (2011) 1.39
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson (2013) 1.31
Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging (2011) 1.30
Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging (2011) 1.27
Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson (2014) 1.26
Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol (2003) 1.17
Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation (2004) 1.16
MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson (2004) 1.13
Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. J Cardiovasc Magn Reson (2011) 1.08
Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease. J Magn Reson Imaging (2012) 1.07
Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol (2006) 1.06
Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA (2003) 1.06
Blood oxygen level-dependent MRI of tissue oxygenation: relation to endothelium-dependent and endothelium-independent blood flow changes. Arterioscler Thromb Vasc Biol (2005) 1.02
Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation. J Cardiovasc Magn Reson (2010) 0.97
CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession. JACC Cardiovasc Imaging (2011) 0.97
Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging (2013) 0.97
Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation. Circ Cardiovasc Imaging (2013) 0.94
Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood. Int J Cardiovasc Imaging (2012) 0.94
Acute chest pain syndrome: will MRI shake up cardiovascular care in the emergency room? Expert Rev Cardiovasc Ther (2007) 0.92
There is more than shape and function. J Am Coll Cardiol (2008) 0.91
Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging (2008) 0.91
Stress-induced cardiomyopathy: a syndrome of the susceptible patient? Expert Rev Cardiovasc Ther (2012) 0.86
Single-shot steady-state free precession can detect myocardial edema in patients: a feasibility study. J Magn Reson Imaging (2009) 0.86
Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging. Eur J Radiol (2009) 0.86
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol (2013) 0.85
Impact of intermittent apnea on myocardial tissue oxygenation--a study using oxygenation-sensitive cardiovascular magnetic resonance. PLoS One (2013) 0.85
Cardiovascular imaging: new directions in an evolving landscape. Can J Cardiol (2013) 0.84
No cardioprotective benefit of ischemic postconditioning in patients with ST-segment elevation myocardial infarction. J Interv Cardiol (2013) 0.84
Cardiovascular magnetic resonance of myocarditis. Curr Cardiol Rep (2010) 0.83
Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J (2006) 0.83
Myocardial edema imaging by cardiovascular magnetic resonance: current status and future potential. Curr Cardiol Rep (2012) 0.82
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study. BMC Cardiovasc Disord (2014) 0.82
Breathing manoeuvre-dependent changes in myocardial oxygenation in healthy humans. Eur Heart J Cardiovasc Imaging (2013) 0.82
Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2006) 0.82
Patent ductus arteriosus with Eisenmenger syndrome. Heart Lung Circ (2013) 0.82
Cerebral and myocardial blood flow responses to hypercapnia and hypoxia in humans. Am J Physiol Heart Circ Physiol (2011) 0.82
Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes. J Endovasc Ther (2004) 0.82
Robust cardiac BOLD MRI using an fMRI-like approach with repeated stress paradigms. Magn Reson Med (2014) 0.81
CV imaging: what was new in 2012? JACC Cardiovasc Imaging (2013) 0.80
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials (2013) 0.80
Stenotic mitral valve prosthesis with left atrial thrombus. J Cardiovasc Magn Reson (2005) 0.78
Testing for myocardial ischemia: the end of surrogates? JACC Cardiovasc Imaging (2010) 0.78
Myocardial infarction after coronary revascularization: role of cardiovascular magnetic resonance oedema imaging. Eur Heart J (2004) 0.78
A closer look on the battlefield: the salvaged area at risk as an outcome marker for myocardial reperfusion. JACC Cardiovasc Imaging (2009) 0.77
Patterns of myocardial late enhancement: typical and atypical features. Arch Cardiovasc Dis (2012) 0.77
A new approach towards improved visualization of myocardial edema using T2-weighted imaging: a cardiovascular magnetic resonance (CMR) study. J Magn Reson Imaging (2011) 0.77
MR coronary angiography using 3D-SSFP with and without contrast application. J Cardiovasc Magn Reson (2005) 0.77
Myocardial oxygenation is maintained during hypoxia when combined with apnea - a cardiovascular MR study. Physiol Rep (2013) 0.77
Detection of papillary muscle infarction by late gadolinium enhancement: incremental value of short-inversion time vs. standard imaging. Eur Heart J Cardiovasc Imaging (2012) 0.76
Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes. Can J Cardiol (2013) 0.76
Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy. Clin Cardiol (2012) 0.76
Cardiovascular magnetic resonance imaging in myocarditis. Prog Cardiovasc Dis (2011) 0.76
Which cardiovascular magnetic resonance planes and sequences provide accurate measurements of branch pulmonary artery size in children with right ventricular outflow tract obstruction? Int J Cardiovasc Imaging (2013) 0.76
Cardiac magnetic resonance imaging: current status and future directions. Expert Rev Cardiovasc Ther (2010) 0.75
Predicting functional recovery in acute heart disease using a single snapshot: we have a winner. J Am Coll Cardiol (2013) 0.75
Reply. Echocardiography (2015) 0.75
Unforeseen cardiac involvement in McArdle's disease. Heart Lung Circ (2013) 0.75
Subscapular tumoral calcinosis in a toddler: case report. J Radiol Case Rep (2012) 0.75
The role of cardiovascular magnetic resonance post-primary percutaneous coronary intervention. Heart (2011) 0.75
T2-weighted magnetic resonance imaging to assess myocardial oedema. Heart (2010) 0.75
Cardiac magnetic resonance imaging of noncompaction cardiomyopathy. Can J Cardiol (2008) 0.75
Images in cardiology. Cardiac magnetic resonance imaging in Löffler's endocarditis. Can J Cardiol (2008) 0.75
Unexpected sequel of chronic Q-fever endocarditis. Heart Lung Circ (2013) 0.75
Meeting highlights of the 9th annual scientific sessions of the society for cardiovascular magnetic resonance: Miami, Florida, January 20-22, 2006. J Am Coll Cardiol (2006) 0.75
Cardiovascular magnetic resonance imaging of abortive ventricular septal defect. Can J Cardiol (2009) 0.75
Evidence for non-ischemic scarring in patients with ventricular ectopy. Int J Cardiol (2011) 0.75
Mitral valve surgery for marantic endocarditis and multiple cerebral embolisation. Heart Lung Circ (2012) 0.75
Patent ductus arteriosus demonstrated in an adult patient using cardiovascular magnetic resonance imaging. Can J Cardiol (2009) 0.75
Giant left atrial appendage aneurysm in a neonate. World J Pediatr Congenit Heart Surg (2012) 0.75
Unconventional modified Fontan operation for Ebstein's anomaly. Eur J Echocardiogr (2011) 0.75
Right ventricular ischemic insult: A comprehensive protocol with cardiovascular magnetic resonance. Anatol J Cardiol (2015) 0.75
Unanticipated stenosis of the systemic arterial supply in scimitar syndrome. Eur Heart J Cardiovasc Imaging (2012) 0.75
Evaluation of left atrial contraction contribution to left ventricular filling using cardiovascular magnetic resonance. J Magn Reson Imaging (2012) 0.75
Unusual cardiac presentation in neurofibromatosis type 1. Eur J Echocardiogr (2011) 0.75
Meeting highlights of the 8th Annual Scientific Sessions of the Society For Cardiovascular Magnetic Resonance, January 21 to 23, 2005. J Am Coll Cardiol (2005) 0.75
Indications, safety and image quality of cardiovascular magnetic resonance: experience in >5,000 North American patients. Int J Cardiol (2013) 0.75
Magnetic resonance imaging of a restrictive atrial septal defect in a univentricular connection. World J Pediatr Congenit Heart Surg (2013) 0.75
Successful catheter-based occlusion of persistent left-sided superior vena cava draining into the left atrium. Eur Heart J Cardiovasc Imaging (2011) 0.75